Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
3.050
+0.010 (0.33%)
Feb 5, 2025, 9:44 AM EST - Market open
Solid Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Feb '25 Feb 5, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 122 | 124 | 105 | 193 | 499 | 205 | |
| Market Cap Growth | 432.15% | 17.92% | -45.57% | -61.33% | 143.92% | -78.45% | |
| Enterprise Value | -25 | 8 | -11 | -34 | 480 | 106 | |
| Last Close Price | 3.04 | 6.14 | 5.38 | 26.25 | 113.70 | 66.75 | |
| PS Ratio | - | - | 12.98 | 14.17 | - | - | |
| PB Ratio | 0.71 | 0.98 | 0.50 | 0.93 | 3.78 | 2.56 | |
| P/TBV Ratio | 1.61 | 0.98 | 0.50 | 0.93 | 3.78 | 2.56 | |
| Debt / Equity Ratio | 0.15 | 0.21 | 0.13 | 0.01 | 0.04 | 0.09 | |
| Asset Turnover | - | - | 0.03 | 0.07 | - | - | |
| Quick Ratio | 7.49 | 8.52 | 9.50 | 8.81 | 6.32 | 4.57 | |
| Current Ratio | 7.85 | 8.94 | 9.76 | 9.43 | 6.49 | 4.72 | |
| Return on Equity (ROE) | -65.79% | -56.79% | -40.96% | -42.43% | -83.24% | -114.24% | |
| Return on Assets (ROA) | -35.33% | -30.67% | -23.95% | -22.38% | -39.35% | -61.36% | |
| Return on Capital (ROIC) | -38.61% | -33.18% | -26.19% | -25.99% | -48.17% | -69.91% | |
| Earnings Yield | -84.34% | -77.50% | -81.84% | -37.40% | -17.69% | -57.28% | |
| FCF Yield | -75.52% | -77.24% | -96.13% | -40.95% | -11.52% | -47.45% | |
| Buyback Yield / Dilution | -98.88% | -133.60% | -19.58% | -105.58% | -28.91% | -21.12% | |
| Total Shareholder Return | -98.88% | -133.60% | -19.58% | -105.58% | -28.91% | -21.12% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.